RHO and neoplasm: Given the activating functions of the RHO GEFs and RHO effectors in the RHO GTPase network signaling, they are typically associated with pro-tumorigenic functions in tumors, whereas RHO GAPs, that are negative regulators, are frequently considered as tumor suppressors.